Research News

An international team of researchers has uncovered a crucial mechanism that allows certain cancer cells to hide from the body’s immune defenses, a discovery that could reshape future cancer treatments. The study, led by scientists at Julius-Maximilians-Universität Würzburg (JMU) in collaboration with partners in the United States, reveals how the powerful cancer-driving protein MYC not only fuels tumor growth but also helps tumors remain undetected by the immune system.

A new epidemiological study reported today finds that consistent heavy alcohol consumption over a lifetime is associated with a significantly increased risk of colorectal cancer, particularly rectal cancer, while reducing or quitting drinking may lower that risk. The findings were published online in the peer-reviewed journal Cancer.

A new peer-reviewed study has revealed that Sanghuangporus quercicola, a medicinal fungus long used in traditional practices across Asia, produces significantly varied secondary metabolites under different cultivation conditions, with notable in vitro antidiabetic activity emerging from the analyses.

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a compound derived from the traditional Chinese herb Salvia miltiorrhiza, on ovarian cancer. The research, conducted by a team from Zhejiang Chinese Medical University and Jiangsu Normal University, reveals that DHT can induce autophagic cell death in ovarian cancer cells by disrupting the sortilin 1 (SORT1)-mediated autophagy–lysosome pathway.